981 results on '"Seghatchian, Jerard"'
Search Results
202. A patient focused application of a non-conventional blood components- autologous serum eye drops – and current opinions on substances used for clinical management of acute haemorrhage for shock/trauma
203. Advances in transfusion science for shock-trauma: Optimising the clinical management of acute haemorrhage
204. Differences between calcium-stimulated and storage-induced erythrocyte-derived microvesicles
205. Platelet microparticles in cryopreserved platelets: Potential mediators of haemostasis
206. Platelet microparticles and cancer: An intimate cross-talk
207. An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful?
208. The multifaceted aspects of blood cell-derived microparticles: An intriguing aspect of my past subject of studies
209. Blood cell-derived microvesicles with potential pathogenic roles in therapeutic blood components and specialized diagnostic tools in diseases
210. The diagnostic usefulness of capture assays for measuring global/specific extracellular micro-particles in plasma
211. Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro
212. Autologous and allogeneic serum eye drops. The Dutch perspective
213. A concise overview of advances in therapeutic efficacy of serum eye drops and their alternatives to treat dry eye syndrome: Verifying the narratives of clinical consistency beyond the periphery of international inconsistency on the methods of collection and application
214. Animal models to assess the therapeutic efficacy of human serum and serum-converted platelet lysates for dry eye syndrome: Seeing is believing
215. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system – An update
216. Symposium on fresh whole blood for severe hemorrhagic shock: From in-hospital to far forward resuscitations
217. Continual advancements in the innovative field of extracorporeal photochemotherapy: Time to wake up, to shake up, to shape up the future direction
218. Quality management in European screening laboratories in blood establishments: A view of current approaches and trends
219. The state of the art of removal of prion proteins in SD-FFP, by specific prion affinity chromatography and its impact on the hemostatic characteristics of the product
220. Multilayer-strategy to enhance optimal safety of the blood supply: The role of pathogen inactivation for optimizing recipient safety and helping health care cost containment
221. Update on pathogen inactivation treatment of plasma, with the INTERCEPT Blood System: Current position on methodological, clinical and regulatory aspects
222. Highlights of PBTI Coimbra Conference on PRT of Plasma & Current Opinions on Pathogen Reduction Treatment of Blood Components
223. The role of uncertainty regarding the results of screening immunoassays in blood establishments
224. Portugal launches two PRT-FFPs to cover the local demands
225. Scheme for the selection of measurement uncertainty models in blood establishments' screening immunoassays
226. Development of blood transfusion product pathogen reduction treatments: A review of methods, current applications and demands
227. Platelet microparticle: A sensitive physiological “fine tuning” balancing factor in health and disease
228. Guest Editor Bio: Remembering the past personal lifetime leaders
229. Evaluation of the measurement uncertainty in screening immunoassays in blood establishments: Computation of diagnostic accuracy models
230. Highlights of the role of PMP in health & disease & advancements in PRT and quality in transfusion establishments
231. Innovative research, improving quality, and celebrating patient successes and the role of donors within transfusion services
232. What is happening? The evolving role of the blood bank in the management of the bleeding patient: The impact of TEG as an early diagnostic predictor for bleeding
233. Analytical model for calculating indeterminate results interval of screening tests, the effect on seroconversion window period: A brief evaluation of the impact of uncertain results on the blood establishment budget
234. Multifaceted regenerative lives of expired platelets in the second decade of the 21st century
235. Storage and handling of blood components – perspectives
236. “Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!
237. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients
238. Ebola virus convalescent blood products: Where we are now and where we may need to go
239. Guest Editorial “REMEMBERING THE PAST PERSONAL LIFE TIME LEADERS”
240. WITHDRAWN: What Is Happening?
241. Scotblood 2011 features advances in translational medicine, haemopoietic progenitor cells and milestones of blood banking systems
242. Scotblood 2010: Key presentations of the past, present, and future of transfusion medicine to mark Scottish national blood transfusion service (SNBTS) anniversaries
243. Cumulative erythrocyte damage in blood storage and relevance to massive transfusions: selective insights into serial morphological and biochemical findings.
244. Red blood cell storage time and transfusion: current practice, concerns and future perspectives.
245. Duration of red blood cell storage and inflammatory marker generation.
246. Unraveling the Gordian knot: red blood cell storage lesion and transfusion outcomes.
247. Spotlight on the impacts of transfusion on patients with Autoimmune Rheumatic Diseases.
248. Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron.
249. SCOTBLOOD 2009: The Quest for Understanding vCJD; Claudia’s Trachea Implantation; Transfusion Triggers; Scottish Histocompatibility and Immunogenetics Network; and Islet Cell Transplantation
250. Pathogen Inactivation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.